Claims for Patent: 5,045,468

Summary for Patent: 5,045,468

Title:	Protein-free culture medium which promotes hybridoma growth
Abstract:	A chemically-defined, stable, protein-free medium has been devised which is capable of supporting the growth of lymphoid cells, particularly hybridomas, even in anchorage-independent cultures. Doubling rates are close to those obtained with serum-supplemented media. The medium preferably comprises a nonproteinaceous organo-iron compound, especially a nitroprusside salt, an iron chelator such as EDTA, and a selenium compound, such as selenium dioxide or sodium selenite.
Inventor(s):	Darfler; Frederick J. (Derwood, MD)
Assignee:	Cell Enterprises, Inc. (Harrisonburg, VA)
Application Number:	07/394,082
Patent Claims:	1. A protein-free culture medium comprising (a) a nonproteinaceous organo-iron compound selected free from the group consisting of a nitroprusside salt and hemin, and (b) a selenium compound, in amounts which, in combination, synergistically promote the growth of hybridomas. 2. The culture medium of claim 1, further comprising EDTA. 3. The culture medium of claim 1, further comprising trace elements. 4. The medium of claim 1 wherein the selenium compound is selenium dioxide. 5. The medium of claim 1 wherein the selenium compound is a selenite salt. 6. The medium of claim 1 wherein the organo-iron compound is a nitroprusside salt. 7. The medium of claim 1 wherein the organo-iron compound is hemin. 8. A method of cultivating hybridoma cells in a protein-free, anchorage independent manner which comprises introducing anchorage-independent hybridoma cells into a protein-free culture medium according to claim 1, and cultivating the cells in the medium in an anchorage-independent manner. 9. The method of claim 8 wherein the cells are cultivated in a spinner culture. 10. The method of claim 8 wherein the cells are introduced into the culture at a seed density of no more than about 10.sup.4 cells/ml. 11. The method of claim 8 wherein the organo-iron compound is a nitroprusside salt. 12. The method of claim 8 wherein the organo-iron compound is hemin. 13. The method of claim 8 where the culture medium further comprises EDTA. 14. The method of claim 11 where the culture medium further comprises EDTA. 15. The method of claim 12 where the culture medium further comprises EDTA.

Details for Patent 5,045,468

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Recordati Rare Diseases, Inc.	PANHEMATIN	hemin for injection	For Injection	101246	07/20/1983		2008-09-03